Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioMedix" found in our extensive corporate database of over 50,000 company records.
KS Biomedix is a biopharmaceutical company with operations in the UK and Canada. It is developing small molecules and biologics for the in vivo diagnosis and treatment of cancer and inflammatory disease
BioMedix is a new biotechnology company that specializes in developing and manufacturing high quality, high performance, cutting-edge ELISA assays. At BioMedix, we are committed to providing the most comprehensive panel of high quality research and diagnostic reagents at the most reasonable prices. We offer products covering the areas of research in cytokines and chemokines, adhesion molecules, ca...
BioMedix is the fastest growing provider of equipment and services in the market for noninvasive detection of peripheral vascular disease (PVD). Unique technology also links PCP's and Vascular Specialists in the early detection of peripheral arterial disease (PAD) through simple web-enabled vascular testing devices, software and services. Innovative Vascular Lab and Surgery suite management softwa...
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of synthetic bioactive peptides. Our patent estate covers...
Helix BioMedix, Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct classes and hundreds of thousands of peptide sequences. Core competencies include peptide design, synthesis and characterization together with assay development, screening, tissue culture and microbiology, leveraged ...
The Venous Disease Coalition (VDC) is an alliance of more than 35 leading health professional societies and patient advocacy groups that have united around a common goal: To improve the survival rates and quality of life for individuals with, or at risk for, venous disease. The VDC plans to develop a national campaign to educate public and health care professionals in the U.S. about venous disease...